In addition, inhibition of the activation of NF-kB with an inhibitor of IKK after AKI (peak in creatinine) prevents the subsequent development of renal fibrosis, a key driver of the development of CKD (Johnson et al., 2017). The gene discussed is NFKB1; the disease is chronic kidney disease.